Status:

COMPLETED

Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure

Lead Sponsor:

German Heart Institute

Collaborating Sponsors:

Miltenyi Biomedicine GmbH

Conditions:

Coronary Artery Disease With Need for Bypass Surgery

Myocardial Ischemia, Angina Pectoris

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Cell transplantation for treatment of heart failure is a novel field of translational research that offers the perspective of developing curative approaches by regenerating or "rejuvenating" lost and/...

Detailed Description

Beginning in 2001, a phase-1 equivalent feasibility and safety evaluation of intramyocardial injection of autologous CD133+ bone marrow cells during elective CABG surgery was conducted at Rostock Univ...

Eligibility Criteria

Inclusion

  • Coronary artery disease with indication for CABG surgery
  • Reduced global left ventricular ejection fraction by transthoracic echocardiography at rest (EF ≤ 35%)
  • Presence of a localized akinetic/hypokinetic/hypoperfused area of LV myocardium for defining the target area
  • Informed consent of the patient
  • Age \> 18 years

Exclusion

  • Emergency operation
  • Presence of aortic valve disease requiring concomitant valve replacement
  • Debilitating other disease: Degenerative neurologic disorders, psychiatric disease, terminal renal failure requiring dialysis, previous organ transplantation, active malignant neoplasia
  • History of ventricular arrhythmia (≥ Lown III)
  • Impaired ability to comprehend the study information
  • Absent informed written consent
  • Apparent infection (CRP ≥ 20 mg/L, fever (≥38.5° C)
  • Acute myocardial infarction
  • contraindication for MRI assessment
  • Pregnancy or lactation

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00462774

Start Date

April 1 2007

End Date

June 1 2011

Last Update

January 16 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Deutsches Herzzentrum Berlin

Berlin, Germany, 13353

Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure | DecenTrialz